1. All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy. (2nd January 2016) Authors: Clements, Derek R; Kim, Youra; Gujar, Shashi A; Lee, Patrick WK Journal: Oncoimmunology Issue: Volume 5:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies. Issue 3 (March 2018) Authors: Gujar, Shashi; Pol, Jonathan G.; Kim, Youra; Lee, Patrick W.; Kroemer, Guido Journal: Trends in immunology Issue: Volume 39:Issue 3(2018) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autophagic homeostasis is required for the pluripotency of cancer stem cells. Issue 2 (1st February 2017) Authors: Sharif, Tanveer; Martell, Emma; Dai, Cathleen; Kennedy, Barry E.; Murphy, Patrick; Clements, Derek R.; Kim, Youra; Lee, Patrick W. K.; Gujar, Shashi A. Journal: Autophagy Issue: Volume 13:Issue 2(2017) Page Start: 264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion. (30th January 2018) Authors: Sultan, Mohammad; Vidovic, Dejan; Paine, Arianne S.; Huynh, Thomas T.; Coyle, Krysta M.; Thomas, Margaret L.; Cruickshank, Brianne M.; Dean, Cheryl A.; Clements, Derek R.; Kim, Youra; Lee, Kristen; Gujar, Shashi A.; Weaver, Ian C.G.; Marcato, Paola Journal: Stem cells Issue: Volume 36:Number 5(2018) Page Start: 641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. NAD+ salvage pathway in cancer metabolism and therapy. (December 2016) Authors: Kennedy, Barry E.; Sharif, Tanveer; Martell, Emma; Dai, Cathleen; Kim, Youra; Lee, Patrick W.K.; Gujar, Shashi A. Journal: Pharmacological research Issue: Volume 114(2016:Dec.) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?. (1st January 2020) Authors: Gujar, Shashi; Pol, Jonathan G.; Kim, Youra; Kroemer, Guido Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?. (1st January 2020) Authors: Gujar, Shashi; Pol, Jonathan G.; Kim, Youra; Kroemer, Guido Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗